New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

OhhMed Medical Ltd., a pioneering medical technology firm specialising in male urology, today announced the initiation of a ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

Researchers at the Vanderbilt Institute for Surgery and Engineering have developed a minuscule robot that could revolutionize surgical procedures for treating prostate cancer, which affects one in ...

Wider resection of localized high-risk prostate cancer at surgery may come at the cost of sexual function and urinary incontinence. A phase 2 trial tested the merits of neoadjuvant therapy.

New UBC research cautions men recovering from a radical prostatectomy to take it easy when returning to work. School of Nursing Professors Joan Bottorff and John Oliffe are scientists with UBC's Men's ...

Erection rehabilitation specifically treats erectile dysfunction (ED) following radical prostatectomy based on a regimented treatment plan implemented before, during and after surgery to mitigate ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...